Literature DB >> 10197824

Transcranial magnetic stimulation: applications in neuropsychiatry.

M S George1, S H Lisanby, H A Sackeim.   

Abstract

In the 1990s, it is difficult to open a newspaper or watch television and not find someone claiming that magnets promote healing. Rarely do these claims stem from double-blind, peer-reviewed studies, making it difficult to separate the wheat from the chaff. The current fads resemble those at the end of the last century, when many were falsely touting the benefits of direct electrical and weak magnetic stimulation. Yet in the midst of this popular interest in magnetic therapy, a new neuroscience field has developed that uses powerful magnetic fields to alter brain activity--transcranial magnetic stimulation. This review examines the basic principles underlying transcranial magnetic stimulation, and describes how it differs from electrical stimulation or other uses of magnets. Initial studies in this field are critically summarized, particularly as they pertain to the pathophysiology and treatment of neuropsychiatric disorders. Transcranial magnetic stimulation is a promising new research and, perhaps, therapeutic tool, but more work remains before it can be fully integrated in psychiatry's diagnostic and therapeutic armamentarium.

Entities:  

Mesh:

Year:  1999        PMID: 10197824     DOI: 10.1001/archpsyc.56.4.300

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  55 in total

Review 1.  Improvement of depression following transcranial magnetic stimulation.

Authors:  M S George; Z Nahas; F A Kozel; J Goldman; M Molloy; N Oliver
Journal:  Curr Psychiatry Rep       Date:  1999-12       Impact factor: 5.285

Review 2.  Transcranial magnetic stimulation: studying the brain-behaviour relationship by induction of 'virtual lesions'.

Authors:  A Pascual-Leone; D Bartres-Faz; J P Keenan
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-07-29       Impact factor: 6.237

Review 3.  Recent advances: Psychiatry.

Authors:  D Lyons; D M McLoughlin
Journal:  BMJ       Date:  2001-11-24

4.  Long lasting effects of rTMS and associated peripheral sensory input on MEPs, SEPs and transcortical reflex excitability in humans.

Authors:  Tetsuya Tsuji; John C Rothwell
Journal:  J Physiol       Date:  2002-04-01       Impact factor: 5.182

Review 5.  Transcranial magnetic stimulation: studying motor neurophysiology of psychiatric disorders.

Authors:  Fumiko Maeda; Alvaro Pascual-Leone
Journal:  Psychopharmacology (Berl)       Date:  2003-06-26       Impact factor: 4.530

Review 6.  The electroconvulsive therapy controversy: evidence and ethics.

Authors:  Andrew D Reisner
Journal:  Neuropsychol Rev       Date:  2003-12       Impact factor: 7.444

7.  Therapeutic effects of individualized alpha frequency transcranial magnetic stimulation (alphaTMS) on the negative symptoms of schizophrenia.

Authors:  Yi Jin; Steven G Potkin; Aaron S Kemp; Steven T Huerta; Gustavo Alva; Trung Minh Thai; Danilo Carreon; William E Bunney
Journal:  Schizophr Bull       Date:  2005-10-27       Impact factor: 9.306

8.  Modulation of cortical oscillatory activity during transcranial magnetic stimulation.

Authors:  Debora Brignani; Paolo Manganotti; Paolo M Rossini; Carlo Miniussi
Journal:  Hum Brain Mapp       Date:  2008-05       Impact factor: 5.038

9.  Bidirectional effects on interhemispheric resting-state functional connectivity induced by excitatory and inhibitory repetitive transcranial magnetic stimulation.

Authors:  Takamitsu Watanabe; Ritsuko Hanajima; Yuichiro Shirota; Shinya Ohminami; Ryosuke Tsutsumi; Yasuo Terao; Yoshikazu Ugawa; Satoshi Hirose; Yasushi Miyashita; Seiki Konishi; Akira Kunimatsu; Kuni Ohtomo
Journal:  Hum Brain Mapp       Date:  2013-07-29       Impact factor: 5.038

10.  Cortical control of affective networks.

Authors:  Sunil Kumar; Sherilynn J Black; Rainbo Hultman; Steven T Szabo; Kristine D DeMaio; Jeanette Du; Brittany M Katz; Guoping Feng; Herbert E Covington; Kafui Dzirasa
Journal:  J Neurosci       Date:  2013-01-16       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.